Stockreport

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

Structure Therapeutics Inc.  (GPCR) 
PDF SAN FRANCISCO, June 05, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral sm [Read more]